Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

NASDAQ:TVTX

Overview | Financials
Company Name Travere Therapeutics, Inc.
Symbol TVTX
Currency USD
Price 21.2
Market Cap 1,889,740,440
Dividend Yield 0%
52-week-range 11.5 - 25.29
Industry Biotechnology
Sector Healthcare
CEO Dr. Eric M. Dube Ph.D.
Website https://www.travere.com

An error occurred while fetching data.

About Travere Therapeutics, Inc.

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric

Related Stocks

Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

XENE

38.19 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

145.2 USD

ImmunityBio, Inc. logo

ImmunityBio, Inc.

IBRX

2.41 USD

Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc.

ESTA

38.245 USD

Addus HomeCare Corporation logo

Addus HomeCare Corporation

ADUS

114.36 USD

Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

LGND

165.86 USD

Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

DVAX

9.7 USD

Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

SUPN

45.82 USD

ModivCare Inc. logo

ModivCare Inc.

MODV

0.432 USD

Financials

Numbers are in millions USD

Numbers are in millions USD